CME Group (NASDAQ:CME) Given New $302.00 Price Target at Jefferies Financial Group

CME Group (NASDAQ:CME) had its price objective lowered by research analysts at Jefferies Financial Group from $304.00 to $302.00 in a research note issued on Monday,MarketScreener reports. The firm presently has a “buy” rating on the financial services provider’s stock. Jefferies Financial Group’s price target would indicate a potential upside of 10.79% from the company’s previous close.

A number of other equities analysts have also commented on CME. Bank of America raised their price objective on CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Keefe, Bruyette & Woods raised their price target on CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. The Goldman Sachs Group cut their price objective on shares of CME Group from $265.00 to $264.00 and set a “sell” rating for the company in a research report on Wednesday. TD Cowen upgraded shares of CME Group from a “hold” rating to a “buy” rating and increased their price objective for the stock from $290.00 to $305.00 in a research note on Wednesday. Finally, Morgan Stanley decreased their target price on shares of CME Group from $320.00 to $319.00 and set an “overweight” rating on the stock in a report on Thursday. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $291.82.

CME Group Stock Performance

NASDAQ CME traded down $2.64 during trading on Monday, reaching $272.59. The company’s stock had a trading volume of 1,673,475 shares, compared to its average volume of 2,080,823. The firm has a 50 day moving average price of $274.12 and a 200 day moving average price of $271.81. CME Group has a 12 month low of $227.89 and a 12 month high of $290.79. The firm has a market capitalization of $98.30 billion, a price-to-earnings ratio of 26.41, a price-to-earnings-growth ratio of 3.47 and a beta of 0.27. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the firm earned $2.68 earnings per share. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. As a group, equities analysts anticipate that CME Group will post 10.49 EPS for the current fiscal year.

Insider Transactions at CME Group

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the sale, the director directly owned 1,091 shares in the company, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the sale, the chief executive officer directly owned 65,804 shares in the company, valued at $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Caldwell Trust Co raised its position in shares of CME Group by 116.3% during the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 50 shares during the last quarter. Highline Wealth Partners LLC lifted its position in shares of CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of CME Group in the 3rd quarter worth approximately $27,000. Financial Consulate Inc. bought a new stake in shares of CME Group in the 3rd quarter valued at $28,000. Finally, Global Wealth Strategies & Associates increased its position in shares of CME Group by 1,250.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after buying an additional 100 shares during the period. 87.75% of the stock is currently owned by institutional investors.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME plans to list futures on Cardano (ADA), Chainlink (LINK) and Stellar (XLM) on Feb. 9 (pending approval), including both standard and micro contract sizes — broadening its regulated crypto derivatives suite and targeting rising investor demand for altcoin exposure. Cointelegraph: CME Group plans launch of Cardano, Chainlink and Stellar futures
• Positive Sentiment: CME issued a formal press release announcing the altcoin futures expansion, reinforcing management’s push to capture more digital-asset trading volume and fees across both institutional and retail segments. PR Newswire: CME Group to Expand Crypto Derivatives Suite
• Positive Sentiment: TD Cowen upgraded CME from Hold to Buy and raised its price target to $305, signaling confidence in CME’s revenue mix and product pipeline (positive analyst support). MSN: TD Cowen upgrades CME Group
• Positive Sentiment: CME is launching a smaller silver futures contract to tap surging retail interest in silver — a move that could increase trading volumes and fee income in metals. Bitcoin.com: Silver Gets a Major Upgrade
• Neutral Sentiment: Morgan Stanley trimmed its price target slightly (from $320 to $319) but kept an Overweight rating, a modest tweak that maintains institutional support but signals little change to the long-term thesis. The Fly: Morgan Stanley price target change
• Neutral Sentiment: Analysts expect single-digit bottom-line growth for Q4; the upcoming earnings release will be a near-term catalyst as investors watch revenue mix (crypto, metals, rates) and trading volumes. Barchart: What to expect from CME Group’s next earnings report
• Negative Sentiment: CME tightened margin calculations in the silver market, linking requirements more closely to price — a risk control move that could damp speculative volume and near-term trading activity in precious metals. Benzinga: CME changes margin calculation for silver
• Negative Sentiment: Despite product launches and upgrades, muted trading volume and broader market pressures appear to be weighing on the stock today — suggesting investors are awaiting concrete volume/fee lifts or the upcoming quarterly results before bidding the shares higher. No external link

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.